
Mitsubishi Eyes $8B Deal for U.S. Shale Assets from Aethon Energy
Jun 17, 2025 03:25 am UTC| Business
Mitsubishi Corp is in advanced discussions to acquire Aethon Energy Managements U.S. shale production and pipeline assets in a deal potentially worth $8 billion, according to a source familiar with the matter. The...

Shell Highlights AECO Advantage in LNG Canada as Exports Near Launch
Jun 17, 2025 03:23 am UTC| Business
Shell CEO Wael Sawan emphasized the strategic advantage of the LNG Canada project due to its use of the Canadian AECO natural gas price index, which is significantly lower than the U.S. Henry Hub benchmark. Speaking at the...

France Shuts Israeli Defense Booths at Paris Airshow Amid Gaza Tensions
Jun 17, 2025 02:42 am UTC| Politics Governance Business
France shut down the main Israeli defense company booths at the Paris Airshow on Monday for displaying offensive weapons, sparking a diplomatic rift with Israel. Major Israeli firms including Elbit Systems, Rafael, IAI,...

Cost Concerns Stall EV Adoption in Europe, Shell Survey Finds
Jun 17, 2025 02:25 am UTC| Business
Drivers across Europe are increasingly hesitant to switch from gasoline to electric vehicles (EVs), according to a global survey by Shell. The 2024 report, based on responses from 15,000 drivers in countries including the...

U.S. Solar Stocks Plunge as Senate Proposes Phase-Out of Tax Credits
Jun 17, 2025 01:47 am UTC| Politics Governance Business
Shares of major U.S. solar energy companies plunged in after-hours trading on Monday after Senate Republicans proposed changes to President Donald Trumps tax and spending bill that would eliminate key clean energy...

OpenAI-Microsoft Rift Grows Amid AI Control and Antitrust Concerns
Jun 17, 2025 01:18 am UTC| Technology Business
Tensions are escalating between OpenAI and Microsoft (NASDAQ:MSFT) as the two AI powerhouses struggle to maintain a once-strong partnership. According to a Wall Street Journal report, OpenAI executives have recently...

Eli Lilly Nears $1.3B Acquisition of Gene Editing Firm Verve Therapeutics
Jun 17, 2025 01:07 am UTC| Business
Eli Lilly and Company (NYSE: LLY) is reportedly in advanced talks to acquire gene editing biotech Verve Therapeutics Inc. (NASDAQ: VERV) in a deal valued at up to $1.3 billion, according to the Financial Times. This move...